Periostin has recently emerged as a promising biomarker of type 2 inflammation in allergic diseases [27], notably induced by signature type 2 cytokines like IL-4 and IL-13 or exacerbating their effects, thereby propagating allergic skin inflammation [28]. This evidence concerns the gene IL4 and allergic disease.